[Update on Current Care Guideline: Diabetic Retinopathy]

Overview

Journal Duodecim

Specialty General Medicine

Date 2015 Aug 5

PMID 26237887

Citations 4

Authors

Paula Summanen

Vuokko Kallioniemi

Jorma Komulainen

Lars Eriksson

Heikki Forsvik

Kustaa Hietala

Sirkku Tulokas

Gunvor von Wendt

Affiliations

Soon will be listed here.

Abstract

Good treatment of diabetes decreases the risk of diabetic retinopathy. The goals of the treatment are adequate glucose balance, blood pressure and prevention of metabolic syndrome. Every patient with diabetes should regularly be screened for diabetic retinopathy. Timely and efficient treatment of retinopathy significantly decreases the risk of visual impairment.

Citing Articles

Comparison of 21 artificial intelligence algorithms in automated diabetic retinopathy screening using handheld fundus camera.

Kubin A, Huhtinen P, Ohtonen P, Keskitalo A, Wirkkala J, Hautala N Ann Med. 2024; 56(1):2352018.

PMID: 38738798 PMC: 11095279. DOI: 10.1080/07853890.2024.2352018.

Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study.

Wirkkala J, Kubin A, Ohtonen P, Ylisela J, Siik T, Hautala N BMC Ophthalmol. 2022; 22(1):258.

PMID: 35681133 PMC: 9178825. DOI: 10.1186/s12886-022-02482-z.

Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy.

Wirkkala J, Bloigu R, Hautala N BMJ Open Ophthalmol. 2020; 4(1):e000390.

PMID: 31909195 PMC: 6936487. DOI: 10.1136/bmjophth-2019-000390.

Deep Learning Fundus Image Analysis for Diabetic Retinopathy and Macular Edema Grading.

Sahlsten J, Jaskari J, Kivinen J, Turunen L, Jaanio E, Hietala K Sci Rep. 2019; 9(1):10750.

PMID: 31341220 PMC: 6656880. DOI: 10.1038/s41598-019-47181-w.